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ABSTRACT
This study presents a process-oriented hybrid model for individuals’ immune responses
and interactions involving vaccination to describe the trend of contagious disease and
estimate the future societal cost. The model considers “recovery” as a non-absorbing
state and incorporates various infection stage states including two symptomatic states.
To model contagiousness to be consistent with the current pandemic and include that
the spread of a disease depends on the mobility of people, we developed an Agent-Based
Simulator that fitted to the particular model used in this study and can test various
what-if scenarios. We improved the simulator considerably by appying data structures
tuned to the specific model used in this monograph. We believe that the simulator’s
performance exceeds existing packages for our particular model. For example, the simulator can deal with a population of one hundred (100) individuals over more than 17,000
iterations in less than seven (7) seconds in CPU time.
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Chapter 1

Introduction
In August 2021 in Korea, more than 50% of the population had received the first doses of Vaxzevria®
(Oxford-AstraZeneca), which is much earlier than the government expected, so the government anticipated that more than 70% (50%) of the population would have received the first (second) doses
by September. However, the government failed to acquire the amount of dosage they needed by the
time that they anticipated, and this caused social confusion and disputes (Kim, n.d.).

Figure 1.1: President Moon Jae-in said through SNS on the 21st, “More than 50% of the people
have received their first doses of the corona vaccine. The rate of administration of the second doses
is getting faster,” said President Moon Jae-in. “We will surely catch the spread by connecting it
with the improvement of the inoculation rate,” he said.
At first, the government suggested cross vaccinations between Vaxzevria and Spikevax® (Moderna)
or Comirnaty® (BioNTech&Pfizer) vaccines. The most popular vaccines, such as Comirnaty, Spikevax, and Vaxzevria, require two doses and the time between doses was determined by the pharmaceutical companies following extensive clinical trials. Korea did not have enough supply of vaccines
to achieve the desired target. Faced with this situation, the government decided to lengthen the period between the first and the second doses: for Vaxzevria from 8 weeks to 12 weeks and for Spikevax
and Comirnaty from 3-4 weeks to 10 weeks, which is not under the guidelines of medical authorities.
Assume that there is not enough supply of the vaccine for every individual to be fully vaccinated
in such a case as Korea, and the second shipment of the vaccine will not arrive before the expected
duration of immunity ends, e.g., 6 months for Comirnaty. One naive solution may be to have as
7

CHAPTER 1. INTRODUCTION
many people as possible partially vaccinated, hoping this is the maximum protection that we can
provide to the entire community until the next shipment arrives. However, is this a reasonable
solution? To answer this question, let us assume the following simplified scenario in a virtual
community with a population size of N . For simplicity of exposition, we assume that the same
vaccine, which requires two doses, is used for the community. Let us take that the vaccination is
immediate, i.e., all vaccinations coincide. If the community receives the number of doses that are
enough for only 50% of the population, Table 1.1 shows some possible scenarios for distributing
these doses among the people.

Total: 50% of the pop.
Partially Vcced (θ)
50
40
30
20
10
0

Fully Vcced (b(50 − θ)/2c)
0
5
10
15
20
25

Vcced
50
45
40
35
30
25

Not Vcced At All
50
55
60
65
70
75

Table 1.1: In our simplified scenario, the number of partially vaccinated people is a control variable
denoted θ. The number of fully vaccinated people is determined as b 50−θ
2 c. The number of vaccinated
people is the sum of both partially and fully vaccinated people, and the rest is considered not
vaccinated at all.

At first glance, as shown in Table 1.1, having as much portion of the population as possible
partially vaccinated might be seemingly reasonable to maximize the number of individuals protected
from the virus. However, this approach has several potential issues. First, the expected duration of
the immunity created by the first dose is not considered. For example, medical advice for Comirnaty
is to administer the second dose three (3) weeks after the first, which means that the immunity after
only the first dose is expected to be below a protection level, and when achieved, this protection
level only lasts a small amount of time. Therefore, based on this seemingly maximal number of 50, if
the government relaxes the pandemic-related restrictions, e.g., lock-downs on airports, businesses,
and restaurants, it might result in chaos with most people ending up infected in only a few weeks.
Also, it can be ethically controversial since the doses that are supposed to be some individuals’
second doses will be used for other individuals in the name of providing a maximal protection for
the entire community. Therefore, this approach is not only inefficient but also unethical. On the
other hand, as in the last row of Table 1.1, if the community decides to have as many individuals
as possible fully vaccinated, then 25% of the population will be fully protected from the virus until
the next shipment arrives. However, the other 75% of the people will be left vulnerable to the virus.
In this monograph, we seek to determine if an optimal answer exists between those two extreme
cases. To do so, we will use the number of partially vaccinated people as our control variable (θ)
and estimate the impact or the cost of the pandemic in terms of the number of hospitalized and
dead people as time passes. We will do so by using a simple simulation modell; however, both the
model and simulator can be adapted to more complicated scenarios as well. Throughout this thesis,
we will use the terms “Agents” and “People” interchangeably.
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1.1. THESIS OUTLINE

1.1

Thesis outline

In chapter 2, we formulate the problem mathematically. In Section 2.1, we discuss how agents move
in the community. In Section 2.2 we discuss both viral transmission and infection. In the first subsection, we see how the virus jumps from a contagious one to a susceptible one. We establish a few
assumptions then provide the formula for the probability for the transmission T r(Su → E). In the
following section, we set up a simple stochastic model to study the evolution of the disease over
time. In Section 2.3 we briefly discuss how the human’s immune system reacts when an antigen
enters the body and relate this to vaccination effects. Then, we discuss how to reflect this in our
simulation model. In Section 2.4, we discuss how to estimate a cost function discussed in Chapter
1, then discuss how to increase efficiency of the simulation.
In Chapter 3, we discuss the implementation of the simulation in detail. We start with a determination of the geometry of the grid for meaningful simulation. Then, we discuss how to design the
simulator and what data structures to use to accelerate the speed of the simulator. After that, we
briefly discuss a variance reduction technique for the simulation.
In Chapter 4, plots involving various what-if scenarios are provided, then we discuss how the
simulator we develop can be helpful in practice and for public health policies.

1.2

Literature review

Ever since the outburst of COVID-19 in 2019, there has been a sudden increase in studies for
modeling the evolution of it to predict its drift since its tendency was unknown to mankind until
then. The majority of those studies found use ODE (Ordinary Differential Equation) methods
based on SIR- (Susceptible Infected Removed) or SEIR-(Susceptible Exposed Infected Removed)
type modeling, which originated from (R. Ross & Hudson, 1917), as most traditional mathematical
epidemiology models do. Such models fail to effectively simulate the trend of the disease that is
thought to be affected by
1) interactions among persons at individual level,
2) geographical or spatial aspects, e.g., safe distance, quarantine,
3) mobility of individuals, and
4) influence of mixed vaccinations.
Also, many of studies based on SIR or SEIR do not represent development of disease that is cognate
with that of COVID-19 in practice. For example, (Y.-C. Chen, Lu, Chang, & Liu, 2020) provides
a SIR model that can deal with undetectable infected persons. 1 In this thesis, the undetectable
infected persons are considered agents exposed to the virus. This will be explained in detail in
Chapter 2. However, in that study, it is not considered that immunization period is finite. Thus,
recovered people as well as dead people are thought to be removed permanently from the model,
as opposed to what clinical studies show, e.g., (W. Liu et al., 2021). (Y. Liu, Srivastava, Huang,
& Vázquez-Abad, 2021) provides data driven SIR-type model that also incorporates statistical
change detection. In particular, that model was capable of detecting changes in social behavior
due to policy changes, as well as the onset of the delta variant, which was detected before it was
described in the scientific literature.
As an alternative, the Cellular Automata (CA) method is capable of modeling populations showing location-dependent characteristics and the stochastic behavior of evolution of disease (White,
9
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Del Rey, & Sánchez, 2007). However, CA theory does not show how the trend of disease is affected
by individuals’ mobility and interactions that depend on spatial conditions (Fu & Milne, 2003).
(Ghosh & Bhattacharya, 2021) uses PCA (Probabilistic Cellular Automata) theory, which is
a variant of CA, to model COVID-19 spread, they consider spatial and temporal variations of the
infection as contributions to it. The study assumes different extents within which an individual is
exposed or infected from others, as well as different density of population depending on locations.
However, although the study is based on a more advanced model, which is SEIQR, where Q stands
for Quarantined, unlike usual SIR- or SIER-type models, it is still not enough to simulate change
in trend of disease influenced by limited immunization period and mixed vaccinations.
ABM (Agent Based Modeling) pursues a bottom-up approach similar to CA, but has a developed capability of tracking the spread of disease (Perez & Dragicevic, 2009). (Perez & Dragicevic,
2009) provides a ABM method that considers various agents’ activities such as commuting, studying, working, and having leisure time that consolidate individuals’ (1000 total) interactions over
time and space. Although mobility, interactions and spatial conditions are main interests of this
study and those are well described in that study, the model that was designed to explain evolution
of contagious disease is as simple as SEIR model. That is, the model may not be so useful for
simulating diseases such as COVID-19 for which immunization is finite. Also, the model seems to
require a great deal of CPU performance and a tremendous memory capacity to deal with tons
of variables considered in the simulation. As a result, the simulation done in the study represents
changes in rate of infection for only 30 days.
In this thesis we blend various techniques and methodologies to build an ABM simulator that
has specifically been tailored to the current COVID-19 pandemic data and how vaccines act to
trigger the immune responses. We provide a process-oriented model that takes into account both
interactions among agents and individuals’ immune responses as factors that describe the trend
of spread of disease. This study provides solutions to inherent challenges that ABM has such as
requiring tremendous running time to simulate with a large population for a long simulation time.
Furthermore, this study also provides a good approximation tool that estimates the future societal
cost that is caused by the pandemic.

10
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Chapter 2

Problem Formulation
The model we consider in this monograph is a hybrid of a timed probabilistic cellular automaton
and a geographic mobility model. We first employ a rectangular grid on which our community
lives, then let people, called agents, transfer their positions with probabilities and rules inspired by
Conway’s Game of Life (see Figure 2.1).

Figure 2.1: An example of Conway’s Game of Life.1
In the CA model, each cell represents an agent and its color represents its state. A state can
change by rules and neighboring agents, thus it can represents interactions among agents. However,
it is difficult to incorporate actual mobility of agents. Our stochastic model for the virus pandemic
is based on both mobility and the immune-response of human beings. Since a viral transmission
can occur when a contagious agent is in close contact with a susceptible one and an agent can be
contagious even when the agent not show any symptoms (Rai, Shukla, & Dwivedi, 2021), including
agents’ mobility is key to model effectively and successfully a pandemic.
Agent-Based Modeling (ABM) for a pandemic can deal with complex phenomena that are
difficult to take into account in other modeling methods. For instance
• The disease evolution is non-Markovian since viral transmissions depend on interactions of
agents. In Section 2.1 and Section 2.2, we will discuss how to reflect this phenomenon in our
1

Source: https://www.pinterest.com/pin/gameoflife--539165386611308311/
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model.
• Disease evolution has latency and incubation periods. We will see how to deal with this in
our model.
• The immunity of an individual is not permanent, i.e., in a finite period, agents who possess
enough antibody titers to be protected from the virus become susceptible to the virus again.
Therefore, as time passes, the numbers of agents in various states may fluctuate. We will
check this in Chapter 3.

2.1

Model for Mobility

To answer our research question, we consider a small virtual community of N agents in a closed
space. This virtual community is assumed to be a rectangular grid consisting of square cells. Each
agent moves at random (uniformly) and at a constant rate across time and cells, and each cell, called
a hyper-cell 2 , can contain multiple agents that are considered being in close contact, e.g., within 6
feet for COVID-19. We assume that agents within a safe distance together make random contacts
among themselves. And then, the virus transmission from those contacts will be immediately and
directly resulting in the simulation, unlike the traditional epidemiology models, (Y. Liu et al., 2021),
(Xu & Xia, 2021), or Markov models e.g., (J. Chen, Fu, Zhang, & Zheng, 2020) and (Xu, Zhang,
& Huang, 2022), where the contact rates are aggregated.
Using hyper-cells can effectively resolve issues that may occur due to using singleton-cells.
Assume two agents, say agent 1 and agent 2, who are currently in {1, 1} and {3, 1} as shown in
Figure 2.2. If both agents want to move to the cell {2, 1}, a collision occurs. Moreover, a collision
can occur even when both agents’ destinations do not collide. For example, assume that agent 1
is in {1, 1} and agent 2 is in {2, 1}, and they want to move by one cell to the right. If agent 2
moves first, both agents can reach their destinations, but if agent 1 moves first, agent 2 has to go
to another cell. Hyper-cells are collision-free because, in our model, we allow multiple occupancies.

Figure 2.2: An example of Conway’s Game of Life.
An agent’s tracking resembles a 2-dimensional Random Walk with more directions. Each time,
an agent chooses one of the following directions at random (not necessarily uniformly): NorthWest,
DueNorth, NorthEast, DueWest, Stay, DueEast, SouthWest, South, SouthEast. More precisely,
given a cell of position (i, j) containing an agent specified by a unique id,
agent[id].pos += {X, Y }
where X, Y ∈ {−1, 0, 1}. For simplicity, in this monograph, we assume that X and Y are independent Uniform random variables with parameter 1/3. For example, if X = −1 and Y = 1, then the
2

In our model, multiple occupancies are allowed for each cell, unlike regular ABS in which each cell can have single
occupancy.
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Figure 2.3: An example of visualization of the community with a population of 100 on the grid with
the dimensions of 14 by 4. Each agent is assigned a unique ID. The bottom two rows, respectively,
represent the hospitalized and dead agents. To see the complete animation of this example, visit
https://github.com/KibumPark/covid-simulation/blob/main/myani.gif

agent moves to the NorthWest direction by one cell, and if X = Y = 0, then the agent stays at the
same position until the next step. Thus, the history of the track for each agent resembles a path of
a 2-dimensional random walk. The only exception is the walking behavior at the boundaries, which
is unavoidable since the dimensions of the gird must be finite in our program. We will explain in
Chapter 3 how to deal with this.

This simple movement can still successfully represent diverse places e.g., large shopping malls,
schools, cruise ships, or any other sites. Furthermore, by modifying the grid or the distributions of
the movements of the agents, we can adapt our model to any situation that should be considered
for disease control.

2.2

Model for Viral Transmission and Infection

In this section, we will provide a diagram that describes state transitions that occur by random
contacts among agents and the changes in the health states of infected individuals. Before beginning,
we first introduce terminologies in Table 2.1.
13

August 20, 2022

CHAPTER 2. PROBLEM FORMULATION
State
Susceptible

Symbol
Su

Description
People who have neither the virus nor enough titers of the antibodies to
the virus.

Protected

P

People who have enough antibody titers

Exposed

E

People who got the virus, but are not yet infected for some reasons,
e.g., the virus is still outside the body or it is already inside the body
but has not bonded to the cells yet.

Mild

IM

People who are infected by the virus and show only mild symptoms.

Severe

IS

People who are infected by the virus and suffer severe symptoms.
People in IS state are hospitalized.

Dead

D

Died from COVID-19.
Table 2.1: Description of states

Finally, agents in P state are assumed to be protected from the virus for a certain time. Model
for protection will be discussed in detail in Section 2.3.

2.2.1

Viral Transmission

In our model, the viral transmission is demonstrated as the transition
T r(Su → E),
which is represented with the wiggly arrow in Figure 2.5. Although the diagram explains an individual’s disease evolution, an individual’s changes in state cannot be cannot be represented by a
Markov process because the transition from Su to E depends on how many contagious people the
agent is within a safe distance. For simplicity, we shall make a few assumptions. For any agent in
state Su in any hyper-cell,
(i) the agent together with the other agents in the same hyper-cell are assumed to be placed
uniformly in that hyper-cell,
(ii) each agent is equally likely to make contact with each other,
(iii) each viral source transmits the virus independently of other viral sources, and
(iv) each viral source has the same probability of transmitting the virus regardless of the actual
distance to the susceptible agent as long as they are within the same hyper-cell.
14
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Under those assumptions, we may compute the viral transmission probability. Suppose that an
agent ai is in state Su and is with n contagious agents c1 , c2 , ..., cn within safe distance. Then,
P [Su → E | ai ] = 1 − P [cj does not transmit the virus to ai , j ∈ {1, ..., n}]
n
Y
=1−
P [cj does not transmit the virus to ai ]
=1−

j=1
n
Y

(2.1)
(1 − P [cj does transmit the virus to ai ])

j=1

= 1 − (1 − P)n
where P represents the per capita rate of viral transmission. Even though P is an important factor
in controlling the pandemic, it is very complicated for us to work out since it depends on various
other factors, e.g., personal hygiene, social distancing, geographical location, temperature, humidity
(Cao et al., 2021). To focus on our research question, we use P = .95 assuming that agents are
lively and energetic, and so they actively make contacts with other agents. However, depending on
the purpose of use of the simulator we are developing, such P can be modified.
To avoid complicating the model, we assume that only the agents who are mobile and contagious
can transmit the virus. Agents in state IS are assumed to be confined, so they are isolated from
the community. Therefore, in our model, only agents in state E or state IM can spread the virus.
See Table 2.2.
State
Su
P
E
IM
IS
D

Mobility
mobile

Contagiousness
—
—
contagious

immobile

—

Table 2.2: Each state belongs to two compartments. We assume that only the agents in state E and
state IM belong to both compartments; can spread the virus to susceptible ones in the community.
We do not consider viral transmissions among already contagious agents. However, by adding
an extra attribute to each agent, we might simulate different variants. If that was the case, we may
add variant attribute so that
ai = { ID, ..., VAR, ..., POSITION }
If we wished to test scenarios concerning both Delta and Omicron variants, we may use two P
values depending on the attribute VAR, Pd and Po , where d and o represent Delta and Omicron,
respectively, with the following formula
P [Su → E | ai ] = 1 − ((1 − Pd )nd (1 − Po )no )
When this is the case, our iid (independent and identical distribution) assumption may not be valid
anymore since each variant has a different transmission rate as medical studies indicate. Therefore,
15
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if the user is interested in such two variants, the user must be cautious and thorough. For instance,
let cd and co denote agents possessing Delta and Omicron variants, respectively. Assume that agent
ai is supposed to talk to both contagious agents. Then, depending on which agent ai contacts first,
the transition probability for ai could be different.
According to CDC guidelines, “safe distance” is measured in the actual distance among people.
Therefore, agents in different hyper-cells might be within a safe distance if they are close to the
same border. However, it is also possible that agents in the same hyper-cell are not within an actual
safe distance. Hence, we postulate that the bias caused by this assumption will be compensated.
See figure Figure 2.4.

Figure 2.4: The two dots in the upper left of the figure represent two agents in the same cell but
are not within the actual safe distance. On the other hand, the other two dots represent two agents
within the actual safe distance but are in different cells. In this monograph, we postulate that each
case compensates for the bias caused by the other case.

2.2.2

Infection

Once an agent in state Su is exposed to the virus, the agent transits either to state IM or back to
state Su. The transition T r(Su ← E) may happen if the virus does not successfully infiltrate into
the body or fail to bond to the cells.3 . Once the virus successfully binds to the cells of the agent,
the agent transits to state IM. Then, the agent transits to state Su, state P or state IS, depending
on his antibody titers. An agent in state P is considered to have enough titers of antibodies and
is protected from the virus. This protection period is not permanent, so the agent will eventually
transit to state Su. We discuss this in detail in Section 2.3. Agents in state IS will transit to state
P, Su, or state D. Figure 2.5 illustrates the transitions among states.

3

For details on auto-immune responses to the virus, see (Vázquez-Abad, Dufresne, & Park, 2022) or (VázquezAbad, 2022)
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Figure 2.5: Six possible states with three compartments. The wiggly arrow from state Su to state
IM indicates that the viral transmission depends on the community. The state P is not absorbing.
With probability 1, every agent in state P will become susceptible to the virus in six (6) or three
(3) months on average. The transitions presented with dashed arrows together with the transition
T r(P → Su) will be discussed in Section 2.3.
Available statistical data provided by other studies were not enough to describe our model; it
was unavoidable to estimate some parameters such as the mean number of days for the transitions
T r(IS → P) and T r(IS → D). (Chung, n.d.) provides the mean number of days for ICU (Intensive
Care Unit) and non-ICU patients, and (Iuliano et al., 2022) provides the ratio of ICU patients to
non-ICU patients. Combining these two data, we compute the mean delays for the two transitions
out of state IS were computed as weighted averages. Although these estimates might differ from
the practice, once more accurate data is released, the user can easily modify the parameters by
such data.
Transition
E → IM
IM → P
IM → IS
IS → P
IS → D

Prob.
.95
.94
0.06
0.84
0.16

Mean
4
14
7
10.65
5.65

Data Sources
(Grant et al., 2022)
(DOHMH, 2022), (Worldometer, 2021), (WebMd, 2022)
(DOHMH, 2022), (Worldometer, 2021)
(DOHMH, 2022), (Chung, n.d.), (Iuliano et al., 2022)
(DOHMH, 2022), (Chung, n.d.), (Iuliano et al., 2022)

Table 2.3: Parameters for the evolution of the disease. The parameters 10.65 and 5.65 are weighted
averages. See table Table 2.4

R ←− IS
IS −→ D

non ICU
10
10
87%

ICU
15
5
13%

Mean Time
10 · 0.87 + 15 · 0.13 = 10.65
10 · 0.87 + 5 · 0.13 = 5.65

Table 2.4: Computation of mean lengths as weighted averages.
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For simplification, we assume here that each state transition of an individual, except for the viral
transmission T r(Su → E), occurs in accordance with the DTMC embedded as a time-homogeneous
CTMC, where time is measured in 15-minute-timeslot and the transition probabilities and mean
sojourn times are provided in Table 2.3. To be precise, let Q and mij , respectively, denote the
matrix of one-step transition probabilities Qij and the mean transition delays, from state i to state
j, according to Table 2.3. Namely,
Su P E IM IS D
Su − − − − − −
P
1
0 0 0
0
0
Q = E .05 0 0 .95 0
0
IM .34 .60 0 0 .06 0
IS .30 .54 0 0
0 .16
D
0
0 0 0
0
1

(2.2)

Furthermore, given agent k and the current timeslot t, let Xt (k), Yt (k), Tt (k), respectively, be the
current state, the next state, the time at which the transition occurs. If Xt (k) 6= Su, we define our
process of state transitions of agent k as the collection of ordered triples



Xt (k), Yt (k), Tt (k) , t ≥ 0

(2.3)


Since the transtion, i.e., T r Xt (k) → Yt (k) occurs when the current timeslot becomes Tt (k), it
follows that if t + 1 < Tt (k),


Xt+1 (k), Yt+1 (k), Tt+1 (k) = Xt (k), Yt (k), Tt (k) ,
if, however, t + 1 = Tt (k), then

Xt+1 (k) = Yt (k),




Yt+1 (k) is determined with probability QXt+1 (k),Yt+1 (k) , and





1
 Tt+1 (k) = (t + 1) + Geo m
,

(2.4)

Xt+1 (k),Yt+1 (k)

For example, assume the following ordered triple for agent k at timeslot 31:


X31 (k), Y31 (k), T31 (k) = E, IM, 511
meaning that agent k currently in state E is supposed to make a transition to IM at timeslot 511.
Then the preceding ordered triple will not change as long as t < 511, so



X31 (k), Y31 (k), T31 (k) = · · · = X510 (k), Y510 (k), T510 (k) = E, IM, 511
Once t = 511, the current state X511 (k) is updated to IM, which is Y510 (k), and the simulator determines the next state Y511 (k) by using transition probabilities provided in (2.2). Assume
that Y511 (k) = IS has been determined. Then, the simulator generates a random
variate from

Geo 1/(7 days) . Assume that 1002 has been generated from Geo 1/(7 days) . Then, T511 (k) is
set to 511 + 1002 = 1513; thus, the ordered triple for t = 511 becomes


X511 (k), Y511 (k), T511 (k) = IM, IS, 1513
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followed by the ordered triples of the same components for t < 1513, i.e.,



X511 (k), Y511 (k), T511 (k) = · · · = X1512 (k), Y1512 (k), T1512 (k) = IM, IS, 1513
Notice that the preceding equation indicates that, for 1002 timeslots, the attributes of agent k does
not change. In Chapter 3, we will discuss how to use this phenomenon to make the simulator work
more efficiently.
Although we assume memoryless jumping among states, a user can easily modify this by merely
using a different distribution for each transition. For example, (Iuliano et al., 2022) shows the
transitions T r(IS −→ (P ∪ Su ∪ D) has mean of 5.5 with a standard deviation of 13.1 and a median
of 3 days of transition time. Since the distribution is continuous, the density should be right-skewed.
Based on this observation, a user may use a right-skewed distribution, e.g., β-distribution for such
a transition. For a hybrid model using a semi-Markov process, see (Vázquez-Abad et al., 2022).

2.3

Model for Protection

Once an agent is vaccinated, it takes time to peak his or her antibody titers. However, it is not
always the case that the peak level reaches L, where L denotes the protection level. (Polack et al.,
2020) shows that after 21 days of the first dose, few people possess the antibody titers at or above
the protection level. 4
Once an agent’s antibody level reaches its peak, it starts going down. Depending on the type
of vaccine, the antibody level either lasts forever above L, e.g., measles, or falls below L after a
certain period, e.g., influenza. Unfortunately, the COVID-19 vaccines developed so far fall in the
latter category.
However, the human autoimmune system preserves the information about the antigen in Memory B-cells to produce the antibodies rapidly when the same antigen enters the human body again.
When the antigen enters the human body for the second time, the immune system generates more
antibodies at a much higher rate than when it encountered the antigen before. Comirnaty, for
example, for 95% of people who receive their second shots, the antibody titers peak in about three
days and stay above L for about six (6) months. (Katella, n.d.) gives a summary of various vaccines with their protection probabilities and periods depending on variants. Such information is
summarized in Table 2.5.5
Vaccine
Comirnaty
Spikevax
Jcovden®
Vaxzevria
Nuvaxovid®

Period b/w doses
3 weeks
4 weeks
Single shot
4 - 12 weeks
3 weeks

Efficacy
95%
95%
72%
85%
90%

Fully effective date
Two weeks after the second dose
Two weeks after the second dose
Two weeks after the vaccination
Two weeks after the second dose
—

Table 2.5: Periods between doses and protection probabilities. Those periods are longer than the
times that the antibody levels take to peak. Jcovden and Nuvaxovid, respectively, are made by
Janssen and Novavax.
4
5

This is why the second dose is suggested on day 21 after the first dose.
Vaxzevria is not available in US so the information was obtained from (MHRA, n.d.).
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Figure 2.6 from (Vázquez-Abad et al., 2022) illustrates development of antibody titers of one
agent over time. In the figure, τj (i) denotes a random time at which the antibody titers at L, so
that the agent is protected at time t if τ1 (i) ≤ t ≤ τ2 (i), where i ∈ {1, 2} represents the doses. If
τ1 (i) does not exist, the antibody titers did not reach L after i doses. For example, a first shot is
administered, it takes the agent τ1 (1) time until his antibody titers reach the protection level L.
After then, the antibody titers stay above L for a short time and then start going down. Beyond
τ2 (1), the antibody titers stay below the protection level, and the agent is no longer protected from
the virus. It should be noted that being protected or not is boolean. That is, the antibody titers
being close to L does not imply better protection than the level lower than L. The agent is infected
if the agent’s immune system does not produce enough antibodies before the virus starts bonding
to the cells and reproducing. Thus, as Figure 2.6 illustrates, an agent with only one dose is not
protected for long.

Figure 2.6: Evolution of antibody titers over time
As briefly mentioned above, the antibody titers might not reach the protection level. Following
the notation in (Vázquez-Abad et al., 2022), we let
πi = P [τ1 (i) < ∞]
That is, πi denotes the probability that an agent with i ∈ {1, 2} doses produces a shield, i.e.,
antibody titers above L. As far as we know, the parameter π1 has not been estimated. (Skowronski
& De Serres, 2021) suggests an estimate with an extensive confidence interval. In this monograph,
we will use π1 = .02 for the simulator. However, if a more accurate estimation is found, the user
can easily change the parameter. For π2 we will use π2 = 95% which is the efficacy of Comirnaty
that is provided in Table 2.5. Also, we assume that everyone in our community is vaccinated with
Comirnaty on the same day, and people having second shots have it on the same day as the first
shots of the partially vaccinated people.6
In our simulation, agents have dynamic attributes in which they keep their information. We
define three protection levels: NONE, PARTIAL and FULL. Although the minimum antibody titers
people possess without any experience of having the pathogen in their bodies depends on the
person, for simplification, it is considered the zero protection level in our simulation. People with
NONE protection level who are not infected are considered being in Su state. On the other hand,
PARTIAL and FULL mean that the people’s antibody levels have reached or exceeded the protection
level L, and thus they are not infected. However, the durations are different, as illustrated in
Figure 2.6. Although τj (i) are random variables, for simplification, we use τ2 (1) − τ1 (1) = 14
days and τ2 (2) − τ1 (2) = 180 days with τ1 (1) = 7 and τ1 (2) = 3 in our simulation. Once more
6

Such mass vaccination occurs in various places, e.g., a daycare center, a boarding school, The Diamond Princess
ship.

20

August 20, 2022

2.4. THE OPTIMIZATION PROBLEM
accurate distributions or estimations for such random variables are released, a user can change the
parameters in the simulator.
For simplification, we also further assume that vaccinations terminate at the start of our simulation (day 0) at once. People who got two doses are assumed to have had their first doses 21 days
prior to the start of the simulation. That is, on day 0, agents with attribute PARTIAL receive their
first doses, and agents with attribute FULL receive their second doses. A reader might think this is
different from reality, but this is actually what happens in such small places that were mentioned
above. For different vaccinations schedules, see (Vázquez-Abad et al., 2022).
Recall that not all vaccinated people can create antibody titers up to the protection level. To
reflect this, on day 0 in our simulator, binomial random variates are generated using θ and two πi ,
i ∈ {1, 2}, to determine which agents will be protected. More precisely, the numbers of people who
receive only one shot or two shots are determined first by θ, then the numbers of people who will
be protected are determined using πi . For example, if the population is 100 and the total amount
of doses is also 100, then with θ = 50%, 50 people will receive only the first shots, and 25 people
will receive the two doses. Thus, X ∼ Bin(50, π1 ) people will be assigned attribute PARTIAL and
Y ∼ Bin(25, π2 ) people will be assigned attribute FULL.
Finally, we assume that agents who recovered from COVID-19 can have antibody titers above
L. However, not all agents who recovered from the disease end up with a shield from the virus.
(Nebraskamed, n.d.) indicates that a third of infections do not get any protective antibodies and
reports that natural immunity fades more quickly than vaccine immunity. To reflect this, in our
simulator, an agent with attribute NONE or PARTIAL can transit to the state P with probability .64,
and even if they successfully transit to the state P, their shields last only about 90 days.

2.4

The Optimization Problem

To find an optimal θ, we consider the number of hospitalized people and the cumulative number of
deaths at time t denoted by Ht (θ) and Dt (θ). Let N be the initial population, and let Xt (k) denote
the same as defined in Section 2.2.2. Then,
Ht (θ) =

N
X

1{Xt (k)=IS}

and

Dt (θ) =

N
X

1{Xt (k)=D}

i=1

k=1

If people die, their family members suffer emotionally and economically. Also, someone must do the
work that was done by dead ones before. Thus, we also postulate that the cost to society caused by
death is directly proportional to Dt (θ). For some constant c our cost function J is then formulated
as
S 

X
J(θ) =
Ht (θ) + c · Dt (θ)
(2.5)
t=1

where S denotes the (random) time periods for which virus exists in the community. We shall call
this the end of pandemic. Although this definition for the end of pandemic might be different from
one that is used in epidemiology, we shall use this term in this monograph since this definition is not
ambiguous; therefore with this definition it is feasible to estimate the societal cost more accurately
caused by the pandemic.
We will not, however, simulate the model until the pandemic ends. We will stop the simulation
at the moment of time at which no more mobile contagious agents are present in the community,
and will estimate the future cost. That way, we may save a huge amount of running time of the
simulations and also reduce the variance.
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Recall that the process of state transitions Xt (k), Yt (k), Tt (k) , t ≥ 0 for an individual is
Markovian EXCEPT for T r(Su → E) that depends on other contagious agents that are present
within a safe distance of the agent. Therefore, if there are no mobile contagious agents present in
the community, then, from that time point, neither viral transmissions nor infections occur any
longer. Define
T = min {t : the time at which no contagious agents are mobile}
0≤t≤S

If the process reaches this time, then the pandemic will end with probability 1 due to the fact
that a geometric random variable is finite with probability 1.7 After time T, under our assumptions, an individual currently in state IS will transit to its intended next state independent of the
past states the person was in or other agents; hence, the sequence of states of an agent becomes
Markovian with no exceptions (because there is no more contagion). Under this circumstance we
can simplify
our Markov

 chain to one that is called Stopped Markov chain. Define the simplified
process Wt (k), Yt (k) , t > T that describes evolution after time T as follows:

Wt (k) =


 Xt (k), if Xt (k) ∈ {IS, D}
 NI,

(2.6)

otherewise.

This definition for Wt (k) is quite intuitive and is much clearer with the state-transition diagram
illustrated in Figure 2.7.

NI

TNI ∼ Geo(1/mNI )
pNI

IS

TD ∼ Geo(1/mD )
pD

D

Figure 2.7: New chain with two absorbing states NI, which stands for Not Infected, and D. An
agent in state NI in the new model is in either state Su or state P. The transition probabilities
and the mean number of days going out of state IS are the same as in the original model. Namely,
pNI = .84, mNI = 10.65 days, pD = .16, mD = 5.65 days.
Our first goal is to prove the following theorem:
Theorem 2.1. Let Ht (θ) and Dt (θ) be the number of hospitalized people at time t and the cumulative number of deaths up to time t, respectively, that are in accordance with the process Wt defined
in Equation 2.6 and illustrated in Figure 2.7. Then,
S 
X
t=1

T 
S 
 X


X
d
Ht (θ) + c · Dt (θ) =
Ht (θ) + c · Dt (θ) +
Ht (θ) + c · Dt (θ)
t=1

(2.7)

t=T+1

Proof. Note that, at time T, there are HT (θ) agents remaining in state IS. Since each agent in state
7

We seem to have a high probability that T is finite, in practice we use truncation.
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IS transits to one of the tree states: P, Su and D, independently of other agents, it follows that
S 
X

S
T (θ) X
 HX
Ht (θ) + Dt (θ) =
1{Xt (k)∈{IS,D} t≥T}

t=T+1

k=1 t=T+1
HT (θ)
d

=

X

S
X

1{Wt (k)∈{IS,D} t≥T}

k=1 t=T+1
def

=

S 
X

Ht (θ) + Dt (θ)



t=T+1

Then, the right-hand side of the equation of the theorem is obtained by linearity of summation.
We now discuss how to estimate the second part of Theorem 2.1
Theorem 2.2. Let Ht,NI and Ht,D denote the number of hospitalized people at time t that will
recover from the disease and die, respectively, and let
Dt (θ) = DT (θ) + D̄t (θ)
where D̄t (θ) denotes the cumulative number of deaths at time t that occurred after time T. Let FT
denote the history of the process by time T . Then,
" S
#

X 
def
JT (θ) = E
Ht (θ) + c · Dt (θ) | FT
(2.8)
t=T+1


= HT,NI (θ)mNI + c DT (θ) + HT,D (θ) E [S − T | FT ] − HT,D (θ)(c − 1)mD
Especially, if c = 1, then


JT (θ) = HT,NI (θ)mNI + DT (θ) + HT,D (θ) E [S − T | FT ]

(2.9)

Note that Equation 2.9 is actually quite intuitive. Given FT , agents who are supposed to recover
from the disease take mNI days on average. On the other hand, the agents who are supposed to die
will keep counting toward societal cost as long as the pandemic persists, i.e., HT,D (θ)E [S − T | FT ]
(The extra term DT (θ) is for those who already died before T). Based on Equation 2.9, Equation
2.8 can be interpreted in a similar manner. The reason the last term is subtracted is because
E [S − T | FT ] contains the time for which agents stay in hospital until the transition to D, so the
hospitalization cost over-counted as part of the death cost is subtracted. Equation 2.9 has no term
to be subtracted since c = 1 implies that societal costs for hospitalization and death are the same.
We shall now prove the theorem.
Proof. Given that an agent in state IS is supposed to transit to D, this agent will stay for TD ∼
Geo(1/mD ) days in hospital until death. Therefore, the societal cost for this agent will be
TD + c · (S − T − TD ) = (1 − c)TD + c (S − T)
giving the mean of
(1 − c)mD + c E [S − T | FT ]
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On the other hand, given that an agent in IS is supposed to recover from the disease, the agent
will stay for TNI ∼ Geo(1/mNI ) days in hospital. Therefore, the mean of the societal cost for this
agent will be just
mNI
(2.11)
Separating from Dt (θ) the dead ones before time T, we have
" S
#
" S
#


X 
X 
E
Ht (θ) + c · Dt (θ) | FT = E
Ht (θ) + c · DT (θ) + c · D̄t (θ) | FT
t=T+1

t=T+1

By linearity of expectation, the right-hand side of the preceding equation is then expressed as
" S
#
" S
#
X
X
c · DT (θ)E [S − T] + E
Ht (θ) | FT + E
c · D̄t (θ) | FT
t=T+1

t=T+1

Since each agent behaves independently of others, using Equation 2.10 and Equation 2.11 gives


c · DT (θ)E [S − T | FT ] + HT,NI (θ)mNI + HT,D (θ) (1 − c)mD + c E [S − T | FT ]
Rearranging the terms in the preceding equation gives


HT,NI (θ)mNI + c DT (θ) + HT,D (θ) E [S − T | FT ] − HT,D (θ)(c − 1)mD
as we desired.
We shall now discuss how to find E [S − T | FT ]. Note that even with a single hospitalized agent,
the pandemic is considered still continuing. That is,
E [S − T | FT ] = E [length of longest hospitalization for any agent | FT ]

(2.12)

Since the sojourn time of the process Wt in state IS conditioning on the next state is geometric,
we shall first formulate the distribution of the maximum of iid geometric random variables to find
E [S − T]. Let G1 , ..., Gn be iid geometric random variables with the probability p of a success.
Then, by the property of max, we have


P max Gk ≤ g = P [Gk ≤ g, for all k ∈ {1, ..., n}]
1≤k≤n

Then, by iid assumption,
P [Gk ≤ g, for all k ∈ {1, ..., n}] =

n
Y

P [Gk ≤ g] = P [G1 ≤ g]n = (1 − (1 − p)g )n

(2.13)

k=1

Since the probability mass function (pmf) of Equation 2.13 is complicated, we shall use the distribution to find the mean by following Fubini’s Principle. If p(·) is the pmf of some nonnegative
random variable, say X, then,
E [X] =

∞
X
x=1

xp(x) =

∞ X
∞
X
x=1 y=x

p(y) =

∞
X
x=1

P [X ≥ x] =

∞ 
X


1 − P [X ≤ x − 1]

(2.14)

x=1
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Refer to Figure 2.8 to see why the second equality of the preceding equation holds. Applying this
to Equation 2.13 gives

p(1)

2p(2)

xp(x)


y


y

p(2)
p(2)

···
···
···
···
..
.

p(3)
p(3)
p(3)

p(x)
p(x)
p(x)
p(x)
..
.

···
···
···
···
..
.

···
···
···
···
..
.

p(x)
p(x)
p(x)

···
···
···
..
.

···
···
···
..
.
..
.

←−

P∞

←−

P∞

y=3 p(y)

y=x p(y)

P∞
Figure 2.8: The horizontal arrow represents the
sum
of
xp(x)’s,
i.e.,
x=1 xp(x). On the other
P∞ P
P∞
hand, the vertical arrow represents the sum of ( x=y p(x))’s, i.e., x=1 ∞
y=x p(y).


E


max Gk =

1≤k≤n

∞ 
X

1 − 1 − (1 − p)g−1

n 

(2.15)

g=1

We are now ready to find E [S − T | FT ].
Theorem 2.3. Let Ht,NI and Ht,D be the quantities defined in Theorem 2.2. Once the time T is
reached, then the pandemic is expected to persist for the additional time period of



x−1 !Ht,NI

x−1 !Ht,D
∞
X
1
1
1 − 1 − 1 −

E [S − T | FT ] =
1− 1−
(2.16)
mNI
mD
x=1

Proof. Given FT . Since each agent of Ht,NI stays in state IS for TNI ∼ Geo(1/mNI ) days and each
agent of Ht,D stays in state IS for TD ∼ Geo(1/mD ),




P [S − T ≤ x | FT ] = P max


max

1≤i≤Ht,NI

TNI (i) ,

max

1≤j≤Ht,D

TD (j)


≤ x | FT

By property of max, then the right-hand side of the preceding equation is expressed as


P [S − T ≤ x | FT ] = P
max TNI (i) ≤ x , max TD (j) ≤ x | FT
1≤i≤Ht,NI
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which is reduced to, by independence,

P [S − T ≤ x | FT ] = P
max

1≤i≤Ht,NI

 
max
TNI (i) ≤ x | FT P

1≤j≤Ht,D


TD (j) ≤ x | FT

Applying Equation 2.13 to the right-hand side of the preceding equation gives


 H 

 H
1 x t,NI
1 x t,D
P [S − T ≤ x | FT ] = 1 − 1 −
1− 1−
mNI
mD
Finally, applying Equation 2.14 to the right-hand side of the preceding equation gives


x−1 !Ht,NI

x−1 !Ht,D

∞
X
1
1

1 − 1 − 1 −
E [S − T | FT ] =
1− 1−
mNI
mD

(2.17)

x=1

as we desired.
Example 2.1. Assume that there are 50 agents in state IS at time T. Suppose that 40 agents of
those 50 will make transitions to NI and the rest 10 agents will make transitions to D at some time
t > T. Then, using pNI = .84, mNI = 10.65 days, pD = .16 and mD = 5.65 days, we estimate


x−1 !40
x−1 !10


∞
X
1
1
1 − 1 − 1 −

E [S − T | FT ] =
1− 1−
10.65
5.65
x=1

≈ 43.955
That is, the pandemic will persist for around additional 44 days, on average.
Remark 2.1. To compute the preceding example numerically, we should set up a proper upper
bound that gives a reasonable approximation. However, we do not know ahead of time what upper
bound for the summation in Equation 2.17 gives us a reliable proxy for the mean. Using a large
upper bound might cause some computation issue (as well as a good deal of running time) as shown
in Figure 2.9. It turned out that using 100 for the upper bound is more than enough as shown in
Figure 2.10.

Figure 2.9: The mean is computed by using Mathematica 13.1 Student Edition. Mathematica
shows some warning messages since it encountered a number that is too small for Mathematica
to handle properly. One solution to this issue is to increase machine precision to a much higher
number. Another solution is to set a threshold and stop if the next addend is less than the threshold. This works always since the distribution is monotonically increasing and so Equation 2.17 is
monotonically decreasing.
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Figure 2.10: The trajectory of approximations of E [S − T | FT ]. The horizontal axis represents
the upper bound of the summation. At u = 100, it has already reached a plateau.
Theorem 2.2 and Theorem 2.3 are useful especially when agents stay much longer in IS than they
do in IM as illustrated in Figure 2.11. As shown in the figure, the simulation stopped at timeslot
76032, but the pandemic is supposed persist until timeslot 87798 (See agent 32). Furthermore,
we throw the timer 87798 and estimate the future cost using only HT,NI , DT,NI and memoryless
property of the geometric distribution.
Furthermore, using Theorem 2.2 and Theorem 2.3 instead of simulating until the end of pandemic
gives us a less variance. Since
##
#
" " S
" S


X 
X 
E E
Ht (θ) + c · Dt (θ) | FT = E
Ht (θ) + c · Dt (θ)
t=T+1

t=T+1

i.e.,
S 
X

"
E [JT (θ)] = E

Ht (θ) + c · Dt (θ)



#

t=T+1

Our JT (θ) is an estimate of
S 
X

"
E

Ht (θ) + c · Dt (θ)



#
(2.18)

t=T+1

However, which one of JT (θ) and

PS



t=T+1


Ht (θ) + c · Dt (θ) is a better estimate of Equation 2.18?

Theorem 2.4. JT (θ) is a better estimate of Equation 2.18
Proof. We use the technique introduced in (S. M. Ross, 2013). Let
Y =

S 
X

Ht (θ) + c · Dt (θ)



t=T+1

Then, by the law of total variance,
Var [Y ] = E [Var [Y | FT ]] + Var [E [Y | FT ]]
implying that
Var [E [Y | FT ]] = Var [Y ] − E [Var [Y | FT ]] ≤ Var [Y ]
Hence, JT (θ) is a better estimate of E [Y ].
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Figure 2.11: Agents in state IS at time T = 76032. Total 26 agents are hospitalized and they
are supposed to recover from the disease, i.e., HT,NI = 26 and HT,D = 0. Some parameters were
modified in such a way that the agents stay longer in IS than indicated in our model.
The intuition behind Theorem 2.4 is that conditioning on the smaller sigma algebra (less information) implies variance reduction. Therefore, if FT contains all information about
(i) who in IS is going to make a transition to D and who in IS is going to make a transition to
NI and
(ii) intended timers at which agents are supposed to make state transitions,
and if all residual clocks follow geometric distributions, then the variance is reduced when considering the minimum necessary information which is (i), because by memoryless property, a geometric
residual clock equals in distribution the geometric random variable. Therefore, we can reduce the
variance by evaluating the expectation.
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3.1

Geometry of Grid

In our simulator, the community consists of 100 agents living in a rectangular area in xy-plain.
We call this rectangular area the settlement. We set the settlement dimensions as [1, 5] × [1, 5], and
each point in the settlement that consists of only integers represents the center of the hyper-cell;
there are 25 hyper-cells in total. The reader might wonder why such dimensions are chosen. If the
population is too big compared to the area of the settlement, e.g., 100 agents living in a single cell,
then everyone is within a safe distance, and everyone will make contact with everyone. If this is the
case, most of them will be sick. On the other hand, if the population is too small, e.g., 10 agents
living in settlement of dimensions [1, 100] × [1, 100], then agents will barely make contacts; thus,
the pandemic will end in seconds.1 Given a population, what can be optimal dimensions for the
settlement? We will begin this chapter by providing the optimal dimensions for settlement that is
needed for our simulation.
Theorem 3.1. Assume that each of N agents has the same probability of being in each cell. Assume
further that agents’ occupancy is independent. Let g be the size of the settlement. Then, the number
of cells that contains two or more agents is expected to be


1 N −1
f (g) = g − N + g − 1 1 −
g

(3.1)

arg max f ≈ .55N

(3.2)



and
g>1

Proof. Let Xi = 1 if the cell i contains two or more agents, and Xi = 0 otherwise. Then,
E [Xi ] = P [Xi = 1]
= 1 − P [No agent in cell i] − P [Only one agent in cell i]
N (g − 1)N −1
(g − 1)N
−
gN
gN
= 1 − (1 − 1/g)N −1 (N + g − 1)/g

=1−

1

For the two extreme cases mentioned in Chapter 1, the simulation ended in 1.795 and 1.414 seconds, respectively.
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Therefore,
def

f (g) = E

"

g
X

#
Xi = g − (N + g − 1)(1 − 1/g)N −1 ,

(3.3)

i=1

as we desired.
Finding the exact quantity of g satisfying
f 0 (g) = 0
is not easy since the equation is neither a polynomial nor an exponential expression in g or N . Although we may speculate that f (g) is unimodal, its rigorous proof should involve showing uniqueness
of g such that f 0 (g) = 0. Thus, in this monograph, we postulate the interesting result in Equation
3.2 by providing plots for some different N values.

Figure 3.1: Plots of f for different values of N . Each plot has the global max at around .55N for
each N ∈ {100, 200, 300}.
In this chapter, we use an initial population of 100 and the dimensions of 8 × 7 (or 14 × 4 for
animation) for the settlement to maximize the chances for the agents to make contact with each
other while they move around the settlement.

3.2

Agents and Attributes

The simulator is coded in Wolfram Language. The most basic data structure in Wolfram Language,
by default, is a list, and most of the data structures used to construct our simulator are lists as
well.
Each agent in the simulator is implemented as a list containing the following seven (7) attributes
{ID, CSTATE, NSTATE, SHLV, TIMER, XPOS, YPOS}
each of which is an integer. The value and the meaning of each attribute of an agent is described
in Table 3.1.
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Attribute
ID

Value
1

Description
ID. Each agent is assigned a unique id starting from 1.

CSTATE

2

Current state

NSTATE

3

Next state

SHLV

4

Shield level.

TIMER

5

The time at which the agent makes a transition to the next state.

XPOS

6

x-coordinate of the position of the agent

YPOS

7

y-coordinate of the position of the agent

Table 3.1: Description of attributes of an agent. The values of attributes are used as part specifiers
and thus are assigned from 1. Wolfram Language does not support 0 as a part specifier of a list.
In the simulator, each agent is an element of another list called agList. For example,
agList[[27]]
returns the list of the seven (7) attributes of the agent with the unique ID 27. To get a specific
attribute of this agent, we use the enum variable that is defined in Table 3.1. For instance,
agList[[27]][[SHLV]]
returns the 4th attribute of agent 27, which is the shield level of the agent.
Since agList is a sorted list by ID’s, we do not actually need the attribute ID to access the
agent’s information. Nevertheless, we keep the ID attribute for each agent. That way, when agList
is printed, the result will be easier to understand and more recognizable for humans.
The health states and the shield levels are also enum variables. The health sates are defined as
{SUSCEPTIBLE = 1, PROTECTED = 2, MILD = 3, EXPOSED = 4, SEVERE = 5, DEAD = 6}
For example, if
In:
Out:

agList[[27]][[CSTATE]]
3

then that means that agent 27 is currently in state IM. Shield levels are defined as
{NONE = 0, PARTIAL = 1, FULL = 2 }
Since each agent can have only one shield level at a time, the shield levels are not used as part
specifiers. Thus, the variable NONE is assigned 0, making it look more self-descriptive.
As we discussed in Section 2.3, just because an agent is vaccinated does not mean that the agent
gets into the state P. An agent who is only partially vaccinated is assigned PARTIAL for the shield
level attribute with probability π1 = .02. If an agent is fully vaccinated, then FULL is assigned with
with probability π1 = .95. The shield level for everyone else is assigned NONE.
Timer is not an enum variable. Whenever a state transition occurs, the simulator assigns each
agent a timer using the agent’s next state and the current timeslot. For example, assume that agent
27 has transitioned to state MILD and has been determined to make a transition to state SEVERE.
Then the program generates the agent’s timer as follows:
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1
agList[[27]][[TIMER]] = timeslot +RandomVariate[GeometricDistribution[ 7∗DAYS
]]+ 1

where timeslot is the current number of iteration, each of which represents 15-minute timeslot,
DAYS is another enum variable of value 4 ∗ 24 since each day consists of 24 hours and one hour
measured consists of 4 timeslots, and finally RandomVariate[GeometricDistribution[p]] is the
built-in command for generating a geometric random variate of parameter p. The 1 is added at the
end of the preceding code snippet to avoid having 0 random variates since we count the number of
trials, not failures.2
A particular case occurs when a susceptible agent is exposed to the virus while the agent is still
creating a shield. We handle that specific case by keeping in a separate list called agCreatingShldList
the agents who were vaccinated and have been in the middle of creating shields since then, where
agCreatingShldList contains the list of such agents’ ID and Timer. When a susceptible agent
whose Timer is, say 288, in agCreatingShldList is exposed to the virus, then the program updates the agent’s current state to EXPOSED, and the following four cases are considered:

(i) becomes MILD at timeslot t1 < 288

(ii) becomes MILD at timeslot t2 ≥ 288

(iii) becomes SUSCEPTIBLE at timeslot t3 < 288

(iv) becomes SUSCEPTIBLE at timeslot t4 ≥ 288

Case (i) represents that the agent’s autoimmune system will fail to create enough antibodies before
the virus reproduces itself. Thus, the agent’s next state and timer are updated to MILD and t1 ,
respectively, and the agent’s ID is deleted from agCreatingShldList. Case (ii) and (iv) represent
that the agent keeps being in state EXPOSED until the agent makes a transition to PROTECTED. Thus,
the agent keeps its original timer and the next state, which is PROTECTED, and is deleted from
agCreatingShldList. Case (iii) represents that the agent becomes susceptible again before the
agent possesses antibody titers reached L. In this case, the agent’s next state and timer are updated
to SUSCEPTIBLE and t3 , respectively, and the agent’s ID is NOT deleted from agCreatingShldList
in case the agent gets exposed to the virus yet again.
As a convention, if an agent’s current and next state are SUSCEPTIBLE, then the agent’s timer
is assigned ∞. Suppose an agent makes a transition to state DEAD. In that case, the next state of
this agent is automatically determined as DEAD and the timer is assigned 0.3 Figure 3.2 together
with Figure 3.3 illustrate how agents are implemented in the simulator.
2

Even if an agent makes a transition at the very next timeslot, it still should count as 1.
This convention is made to be consistent with the cases (i) and (iii) above and makes the model more realistic. If
the timer is ∞, then any new timer is always less than the current timer so that the agent can make a transition. If
the timer is 0, then any new timer is always greater than the current timer, so the agent will not make a transition.
3
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Figure 3.2: An example of truncated agList. Modified parameters are used to illustrate all types
of agents at once. Compare the attributes of agents 1, 14 and 24 to those in Figure 3.3.

Figure 3.3: Visualized form of agList. For example, the first line of this table indicates that agent
1 in Cell {14, 3} is currently in state PROTECTED and is supposed to lose the shield at the time of
691 timeslot. The shield level indicates that the agent was either never vaccinated or is vaccinated
but failed to create a shield. Modified parameters are used to illustrate all types of agents at once.
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3.3

Vaccination

Although, for simplicity, we simulate under the assumption that vaccination terminates on day 0,
other vaccination schedules can be coded in our simulator. A vaccine is administered to only those
who are (obviously) alive and do not show any symptoms. In our model, all such agents are in state
either Su or E. The simulator keeps these types of agents separately from the other types of agents.
Thus, different vaccination schedules can be implemented easily in accordance with the four cases
described in Section 3.2. Although the four cases are for susceptible agents, those are applicable to
when an exposed agent is vaccinated.

3.4

Caching Matrix

We argued that the transmission probability P [Su → E] for an agent depends on the number of
contagious agents that are in the same cell, namely,
P [Su → E | agList[[id]]] = 1 − (1 − P)contgij

(3.4)

where, contgij represents the number of contagious agents in Cell {i, j}, given that
agList[[id]][[XPOS]] = i
agList[[id]][[YPOS]] = j
Thus, we create cachMat of the same dimensions as our settlement
cachMat = Table[0, {i, 1, XSIZE}, {j, 1, YSIZE}]
and increase {i, j} entry of the matrix by 1 whenever a contagious agent is relocated into the cell
{i, j}. The matrix in (3.5) is an example of cachMat.


0 0 1
0 5 0
(3.5)
2 2 0
In (3.5), 1 in (1, 3) entry of the matrix means that there is one (1) contagious agent in cell {1, 3}.
Similarly, there are five (5) contagious agents in cell {2, 2}. The cachMat is reset to the zero matrix
at the end of each iteration.
Although we cache the number of contagious agents in each cell, we do not cache the transmission
probability for each cell since we want to avoid sorting susceptible agents by position. Given n
agents, sorting the agents by position takes O (2n) since they should be sorted by x-coordinate
first and then y-coordinate. Furthermore, the result of some experimental test (Figure 3.4) shows
that the cost for accessing and getting a number from a cachMat is even similar to computing the
transmission probability in Equation 3.4 in Mathematica.

Figure 3.4: Out[126] is the average cost for accessing and getting the probability, which is zero, from
cachMat. Out[127] is the average cost for computing the transmission probability with a random
exponent less than or equal to the population. There is no practical difference between the time
costs for those two operations.
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3.5

Data Structures for States

As already mentioned, the step size for each iteration of our program represents a 15-minutetimeslot, and thus one day consists of 4 ∗ 24 = 96 timeslots in the simulation. Since each transition
delay is measured in days, the size of a random variate generated by the program is actually quite
big in timeslot. For example, assume that agent ai is supposed to make a transition from state
MILD to state PROTECTED. Then, to set the timer of agent ai , the program will first generate the
following:
RandomVariate[GeometricDistribution[1/(14*DAYS)]]
which is actually equivalent to
RandomVariate[GeometricDistribution[1/1344]]
Assume that the preceding command results in 3988. Then, the program will keep checking
agList[[id]][[TIMER]]
unnecessarily for 3988 times to see whether or not it is time for the agent ai to make a transition,
which is a total waste of time. If the program has to check each agent’s timer every timeslot, each
iteration takes O (N ) lengthening the total run time of the program. Even if the simulation time is
only 180 ∗ DAYS, since 180 ∗ DAYS = 17 280, the time complexity of the program will be T (17 280N ).
Our goal is to reduce the expected time complexity for a state transition of an agent per timeslot
from O (1) to a small number, which we denote by ε > 0.
Our approach is to use priority queues for agents in states EXPOSED, MILD, PROTECTED and
SEVERE, where priorities are given by agents’ timers in such a way that the less the timer is,
the higher the priority is. For example, assume that an agent is currently in state E and has the
smallest timer among all agents in the same state. Since it is well known that peek ing the element
with the highest priority in a priority queue can be done in O (1) time, we can check in O (1) time
whether or not the agent’s timer is greater than the current timeslot. If the timer is greater than
the current timeslot, then that means that the agent is NOT supposed to make a transition out
from the current state; hence none of the other agents in the same state also does make a state
transition out from the current state. Therefore, when that is the case, no matter how many agents
are currently in state E, it takes the program only O (1) time to perform state transitions since
it will skip all the other agents. An exception might occur when one or more agents are pushed
into or popped from the same priority queue since it takes O (log n) time to pop/push an element
from/into a priority queue of size n. We will show that even for such a case, the time complexity
for a state transition for an agent is ε. As a starter, let us see how the priority queues are defined
and used in the simulator.
To begin, assume six (6) data structures, each of which is named as either
dsIDPQ[state]
if state ∈ {PROTECTED, MILD, EXPOSED, SEVERE}, or
dsIDList[state]
otherwise, where dsIDList is a linked list. Since the viral transmission occurs instantaneously in
our model and dead agents do not make state transitions anymore, there is no reason to store ID’s
of the susceptible and the dead agents in priority queues sacrificing the simulator’s performance.
Additionally, we need one more data structure called dsBuffer, a linked list, to prevent agents
from making state transitions multiple times per timeslot. To create such data structures, we use
the following one-line commands:
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CreateDataStructure["LinkedList"],
for a linked list, and for a priority queue,
CreateDataStructure["PriorityQueue", {}, orderf unc],
where orderf unc is a specified ordering function in that priority queue, and the pair of curly
braces is there to keep the ordering function in the third position of the command. We establish
the ordering function for each priority queue by using the built-in command Order[expr1 , expr2 ]
defined as follows:

 1 if expr1 < expr2 ,
0 if expr1 = expr2 , and
Order[expr1 , expr2 ] =

−1 if expr1 > expr2 ,
where we use the timers for expr1 and expr2 . Since each priority queue is supposed to contain
agents’ ID’s, not the timers, to use the timers as the arguments of the ordering function, we need
to call the timers by using stored ID’s in the priority queue. To do so, we use
agList[[idj ]][[TIMER]]
for exprj , j ∈ {1, 2}. WOLG, assume that expr1 < expr2 . Then, by default, Mathematica assigns
id2 a higher priority than id1 . Note, however, that in our priority queues ID’s with smaller timers
are supposed to have higher priorities. Therefore, we negate the expressions so that
Order[−expr1 , −expr2 ]
returns −1, i.e., id1 has a higher priority. Taken together, we define the ordering function as
Order[−agList[[#1]][[TIMER]], −agList[[#2]][[TIMER]]]&

(3.6)

where #1, #2 and & are needed so that Mathematica uses (3.6) itself as a function.4 Finally, the
following command creates the four (4) priority queues we need:

Figure 3.5: Do loop is used to keep the iteration variable state local. state varies from PROTECTED
to SEVERE, i.e., from 2 to 5.
Nextly, state transitions proceed in accordance with the following sequence of rules:
1. Iterate through dsIDList[SUSCEPTIBLE] and pick agents’ IDs who were exposed to the virus.
Push those IDs into dsBuffer.
2. Peek dsIDPQ[state].
4

def

For example, f (x(t), y(t)) in (f ◦ c)(t) = f (x(t), y(t)) is often used ambiguously. Sometimes it is used as the
image of t under the composition of f on c, or as another form of f ◦ c. The latter is what (3.6) means.
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3. For Peek ed ID, say id, if agList[[id]][[TIMER]] is equal to the current timeslot, then
(a) make a state transition for agent agList[[id]],
(b) pop id from the priority queue, and
(c) push id into dsBuffer.
Repeat this until the timer greater than the current timeslot appears. If such a timer appears,
skip.
4. Repeat the steps 2 - 3 for PROTECTED ≤ state ≤ SEVERE.
5. Release dsBuffer so that ID’s in dsBuffer go to appropriate data structures.
The above steps are implemented as shown in Figure 3.6 and Figure 3.7.

Figure 3.6: For each state in the range, the while loop checks if the priority queue is not empty
and the timer of the agent with the highest priority equals the current timer. If then, id is popped
and it together with the current timeslot is sent to another function called evolve-disease. id
is not explicitly written in the code since the return values of dsIDList[state]["Peek"] and
dsIDList[state]["Pop"] are id’s. Mathematica automatically heapifies when an id is popped.

Figure 3.7: The function evolve-disease. If the agent is alive, it updates the agent’s current
state and the intended next state, respectively, to the intended next state and SUSCEPTIBLE. And
then, the agent’s id and the current timeslot are sent to another function called setNext which
determines the agent’s next state based on the current state and timer based on the next state. If
the agent is dead, the function directly sends the id to dsIDList[DEAD] since the agent will not
change his state anymore.
The function setNext in the code snippet above is too long to be inserted as a code snippet in
this chapter since it behaves differently depending on the agent’s current state, shield level, and the
next state (to determine the timer). In brief, setNext basically does three things in order. It first
determines the next state of the agent based on the current state and the transition probability. It
next determines the timer conditioned on the next state. Finally, it sends the ID to dsBuffer. The
simulator then releases dsBuffer. State transitions described in steps 1 - 5 and the implementing
codes are conceptually illustrated in Figure 3.8 and Figure 3.9.
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Figure 3.8: Buffer-in. Agents 3 and 5 were exposed to the virus, so their IDs were pushed into the
buffer. Agent 10 developed his symptom, and agent 7 recovered from the disease; thus, they are
all pushed into the buffer. The antibody titers of agent 18 have fallen below the protection level;
therefore, the agent becomes susceptible to the virus. Unfortunately, agent 22 died. Each of the
other ID’s in the figure represents the ID with the following priority in the queue. Once the ID of
the highest priority is popped, Mathematica automatically heapifies the queue i.e., pushes up the
ID of the next priority all the way to the top node.

Figure 3.9: Buffer-out. All transitions have been made, and the ID’s of the second priorities in
the previous figure have been pushed up to the top nodes. All ID’s in dsBuffer are released by
the simulator and sent to appropriate data structures. Once a new ID is pushed in, Mathematica
automatically heapifies the queue again until it regains the heap property.

We now argue that the average time complexity for a state transition for an agent per timeslot
is ε. Since we do not know the size of each priority queue ahead of time, we postulate that each
agent’s total number of state transitions over 180 days is relatively (quite) small, approximately 10.
This postulate is reasonable as described with some experimental results in Figure 3.3 and Figure
3.10.
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Figure 3.10: Records of state transitions of two agents. The left one made transitions nine (9) times
for 180 days. On the other hand, the other one made transitions only four (4) times for 180 days.
Those two agents’ average number of transitions for 180 days is only 6.5.

Figure 3.11: The four code snippets show the average number of transitions for 180 days is ≈ 10.
The top two codes were run with population of 30 on a 4 by 4 settlement. The bottom two were
run with population of 100 on a 8 by 7 settlement. The control variable θ for the upper left and
lower left was set to 0% when the total number of doses available is 50% of the population. The
control variable θ for the upper right and lower right was set to 50%.
The average costs for insertion/deletion for dsIDList[SUSCEPTIBLE], dsBuffer and dsIDList[DEAD]
are all inconsiderable since they are linked-lists5 , no agents in those lists are over-counted unnecessarily, and not all agents are pushed into those lists. Nevertheless, for simplicity, we assume that
each of those seven (7) data structures of size n costs O (log n) for a push/pop, which is much
greater than the actual cost, then argue that the average cost for a state transition for an agents
per timeslot is still ε.
Theorem 3.2. The average time complexity for a state transition for an agent per timeslot is ε.
5

It is amortized O (1) for even Deletion operation since our program checks each element in the linked list.
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Proof. Assume that the seven data structures are all priority queues. And further, assume that
the average number of transitions per agent over 180 days is 10. Then, the average cost for state
transitions for N agents for 180 days is
2 · 10 · N · O (log N ) + 7
where 2 is for both a push and a pop and 7 comes from the fact that peeking the seven heaps occurs
every timeslot. Hence, the average cost for a state transition for an agent during one timeslot is
2 · 10 · N · O (log N ) + 7
1
7
=
O (log N ) +
N ∗ 180 ∗ DAYS
864
17280N
Notice that

1
O (log N ) ≈ 0
864

unless N is 1.23 × 10178 times as big as the total number of atoms in the universe.6 Also, obviously
7
≈ε
17280N
which supports our claim.
Remark 3.1. With priority queues, significant improvement in running time has been achieved.
For example, without using such data structures, simulation with 20 agents on a settlement of
dimensions 5 by 5 over 180 days took 16 seconds in CPU time. On the other hand, using the data
structures explained above, simulation under the same condition took only 1.8 seconds in CPU time.
For 100 agents on a settlement of dimensions 8 by 7, the old one took 72 seconds in CPU time,
and the improved simulator takes, on average, 7 seconds in CPU time.
Remark 3.2. We do not actually have to relocate agents in state P since, under our assumptions,
they are neither contagious nor susceptible to the virus. The tests mentioned in the remark above
were run without relocating agents in state P. If agents in state P are relocated, our improved
simulator takes about 17 seconds in CPU time for 100 agents on the same settlement above over
180 days. The old one was not tested under this condition, but it would have taken a couple of
minutes.

3.6

Agents Relocation and Variance Reduction

The simulator relocates live agents at the end of each iteration over timeslot. Similar to Moore
neighborhood (White et al., 2007), each agent has nine (9) directions to move as explained in
Section 2.1. However, the number of possible directions is not always nine (9) since an agent can
be in a cell at the settlement’s boundary. For example, if an agent is at the left boundary of the
settlement, then the only possible x-directions for the agent to go are stay and the right direction.
Horizontal movements for an agent are illustrated in Figure 3.12. (Vertical movement also has
similar limitations.) Considering all those limitations, the simulator relocates agents as shown in
Figure 3.13.
6

2

864

Scientists speculate that 1082 is an upper bound for the total number of atoms in the observable universe. Then,
/1082 ≈ 1.23 × 10178 .
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Figure 3.12: There are three (3) possible cases including two exceptions for horizontal movement. The first and the third case, respectively, indicate that agList[[id]][[XPOS]] == 1 and
agList[[id]][[XPOS]] == XSIZE, where XSIZE represents the horizontal length of the settlement.

Figure 3.13: The simulator determines the agent’s horizontal direction and vertical direction separately. If the agent is contagious, then cachMat is updated.

To obtain more reliable results, it is necessary to repeatedly simulate each value of the control
variable θ. However, each simulation results in a different value of J(θ) from the previous one.
Given θ, in order to reduce the variance of estimates for J(θ), we use common random numbers.
Let T = (T1 , T2 , ..., Tn ) and T∗ = (T1∗ , T2∗ , ..., Tn∗ ) be iid random vectors, and let g and h be two
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functions. Then,7
Var [g(T) − h(T∗ )] = Var [g(T)] + Var [h(T∗ )] − 2 Cov [g(T) − h(T∗ )]
= Var [g(T)] + Var [h(T)] − 2 Cov [g(T) − h(T∗ )]

(3.7)

Therefore, if g(T) and h(T∗ ) are positively correlated, then the variance in Equation 3.7 will be
smaller. Thus, using the same T for both g and h instead of generating an iid random vector
T∗ results in a smaller variance. In our simulation, we use agents’ positions as common random
numbers. To do so, we generate all possible directions for each agent for each timeslot, then use
them for every simulation. Namely, first generate a random matrix called randPosList as shown
in Figure 3.14.
The list randPosList is a matrix of dimensions of
POPULATION by 2 by 3 by DAYS
where 2 indicates x- and y directions and 3 indicates three different types of boundary properties
explained above. For example, the entries in the red box in Figure 3.14 are vertical directions for
agent 1 when the agent is at neither the settlement’s leftmost nor the rightmost boundary.

Figure 3.14: Visual illustration in matrix form of an example of randPosList with POPULATION = 5
and only 10 timeslots. The two matrices in each row, where 1 ≤ row ≤ 5, contain agents’ horizontal
directions and vertical directions, respectively. The three rows in each submatrix contain possible
directions depending on whether the agent is at a boundary of the settlement. Each submatrix’s
ten (10) columns represent ten (10) timeslots.

7

The following explanation is from (S. M. Ross, 2013)
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Conclusion and Discussion
4.1

Results

In our case study, we consider that the number of doses equals the population. We use the same
parameters and the geometry of the settlement we discussed in Chapter 2 and Chapter 3. Recall that
our control variable θ represents the percentage of the population that will be partially vaccinated.
For example, if θ = 70, then we partially vaccinate 70% of the population (since we have the same
number of doses as the population) and use the rest 30% to vaccinate other people fully. Therefore,
among 100 people, 70 will be partially vaccinated, and 15 will be fully vaccinated. The following
plots are results for various θ values.

Figure 4.1: θ = 100, 80, 60, respectively

Figure 4.2: θ = 40, 20, 0, respectively
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The three plots in Figure 4.1 are obtained using θ = 100, 80, 60, and the three in Figure 4.2 are
obtained using θ = 40, 20, 0, respectively. One interesting feature is that regardless of θ, most
people end up with shields. It is because the recovery rate is quite high, even for those who are not
vaccinated at all. Recall that the recovery rates from IM and IS are 94% and 84%, respectively.
However, this does not mean that elongating the period between the first and the second shots does
not increase the societal cost.
First, the increasing rate of the blue when θ = 100 is much slower than other θ’s. It is because
only about 2% of partially vaccinated people can create shields. Therefore even though all the doses
are used for partial vaccination, most of them failed to have antibody titers reach the protection
level.
Second, there are high humps over the first 2000 timeslots, among which the one with θ = 100
is the highest. It is because the partially vaccinated people failed to create shields, and they all
got sick. Even though most of them can recover from the disease, we see that many people are ill
during the first 2500 timeslots, which is around a month. During those days, the sick people should
stay home and not go to work, etc., i.e., not engage in economic activities, etc., thus causing costs
to society.
Finally, the brown tail for θ = 100 is much thicker than that for θ = 0. That means that the
overall societal cost for θ = 100 is much greater than that for θ = 0.
Attentive readers might wonder why there are no noticeable green curves representing susceptible agents. According to our assumptions, viral transmission is instantaneous, and all agents are so
lively and energetic that they actively interact with other agents. Thus, once an agent becomes susceptible by recovering from the disease or losing the shield, the agent makes contact with contagious
agents and gets exposed to the virus again.
We shall end this section with one remark. Although the results show that whether or not a
person is vaccinated, the person will end up having antibody titers reached the protection level,
this does not mean that the agent will be as healthy as those that are not infected by the virus.
We have been with the virus for only two or three years; thus, we do not know well, in the long
run, what after-effects there are or how long those after-effects last. Therefore, the results of this
study must not be used to back anti-vaxxers claims.

4.2

A what-if scenario

As an example, let us assume a different contagious disease. This disease is less contagious than
COVID-19, but for some reason, most (90%) of infected people fail to create shields even if they
recover from the disease. Fortunately, a vaccine is invented and it works very well: π1 = .2 and
π2 = 1.0. That is, 20% of partially vaccinated people can successfully create shields, and all fully
vaccinated people can create shields. Furthermore, partially vaccinated people can be protected for
about 90 days. For simplicity, assume that τ1 (1) = τ1 (2) = 0, that is, antibodies peak without any
delay. Assume further that P [E → IM] = .5, P [IM → P] = .5, and everything else is the same as
our original model. The following are the results of simulations of 180 days for the same θ’s as we
had above (One replication each).
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Figure 4.3: θ = 100, 80, 60, respectively

Figure 4.4: θ = 40, 20, 0, respectively
Interestingly enough, even though the disease is less contagious than COVID-19, the vaccine
works better than those for COVID-19; it is clear that the lower the θ, the less the societal cost. Note
also that the plot for θ = 0 has the highest blue curve and the lowest black curve. Interestingly, fully
vaccinating as many people as possible does not lower the red and blue curve that much compared
to the opposite case, i.e., θ = 100.

4.3

Discussion

We end this chapter by discussing capabilities and limitations that require future work of the
simulator we have developed through this thesis.

4.3.1

Capabilities of the Simulator

As a capability of the simulator, we shall discuss how to modify the code to incorporate the virus
variants, especially Delta and Omicron. As far as we know, it is not known if both variants can
infect a person or one variant defeats the other, i.e., if a person is infected by Delta and then is
exposed to Omicron, then Omicron might defeat Delta or vice versa. By simulating both cases,
we might discover possible but unknown future scenarios that should be prepared for or may help
decision makers such as a mayor, principal, senior center director, and so forth.
Since we have two variants, as briefly explained in Section 2.3, we may add new attribute VAR
and add two additional enum variables DELTA and OMIC. For example, an agent’s attributes can be
defined as
{ ID=1, CSTATE=2, NSTATE=3, SHLV=4, TIMER=5, VAR=6, XPOS=7, YPOS=8 }
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then define
{ DELTA = 1, OMIC = 2 }
Then, the program checks the variant that an agent is exposed to or infected by checking
agList[[id]][[VAR]]
Now, pass the agent’s ID together with the current timeslot to the function setNext:
setNext[ timeslot, agList[[id]][[CSTATE]] ]
The return value of
agList[[id]][[CSTATE]]
is an agent’s state. Adding an If[ ] statement in the function setNext[state] can make it handle
the variant.
Or, we might modify the agents’ movement. Currently, each agent in our simulator moves at the
same rate in a random direction. The function which controls agents’ mobility is relocateAgent,
which takes the current timeslot and an agent’s ID as the arguments. By simply modifying or
adding rules that depend on an agent’s ID, the simulator can be adapted to situations that involve
more complicated geometry of the settlement.
The simulator can be helpful not only for COVID-19 but also for controlling any contagious
disease in a closed space. By changing the parameters or agents’ mobility, the simulator can provide
reliable results in seconds with not only trajectories of statistics but also animation. The animation
shows much more information than a graph, e.g., how mobility affects the spread of the disease
and which part of the settlement has a higher priority to be disinfected. All such information can
be obtained from the simulator and a user’s input.

4.4

Future Work

There are limitations of the simulator too. Wolfram Language is not a good choice for using data
structures. Wolfram Language was chosen for visualization since it provides many useful builtin functions for visualization. Still, to develop the simulator further so that it can handle more
complicated rules, geometry and mobility, it should be written in a different language. C is a good
candidate for performance when more complex rules and geometry are involved. Julia is also a good
candidate which is specifically targeted for high efficiency in scientific programming.
Unfortunately, the optimization experiment has not been completed since time did not permit.
One can do experiment optimizations on various scenarios using the theorems we developed in
Section 2.4.
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